WILLIAM TENNANT: Open Payments
NPI 1871026609 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 30 payments from 8 companies in 2025. Trend: 2023 $385 · 2024 $462 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 16 | $190 |
| Corium, LLC | 8 | $92 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Tris Pharma Inc | 1 | $15 |
| Alkermes, Inc. | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: Qelbree, Azstarys, SPRAVATO, VRAYLAR, CAPLYTA, Onyda XR, ARISTADA, Auvelity.
Industry payments across AL — which companies pay providers there.
